4-Fluoro-7-sulfamoylbenzofurazan ABD-F fluorogenic fluorescent labelling 50mg Wako

4-Fluoro-7-sulfamoylbenzofurazan (ABD-F) 50mg produced by Dojindo Laboratories and distributed via FUJIFILM Wako Chemical Corporation

ABD-F has a benzofurazan moiety that produces a highly fluorescent compound through the reaction with a sulfhydryl group. The excitation and emission of the derivative compounds are 389 nm and 513 nm, respectively.

The reaction rate of ABD-F is 30 times faster than that of SBD-F. ABD-F reactions with thiol compounds are completed within 5 minutes in aqueous conditions at 50ºC, pH 8. However, ABD-F does not react with alanine, proline, or cysteine under these conditions. Its maximum fluorescence intensity can be observed at pH 2.

In reverse-phase HPLC analysis, pre-labeled ABD-thiol compounds can be detected separately. The detection limits (S/N=3) are 0.6 pmol per injection for cysteine, 0.4 pmol per injection for glutathione, 1.9 pmol per injection for N-acetylcysteine, and 0.5 pmol per injection for cysteamine.

ABD Labeling Protocol:
1. To prepare sample solution, mix or dissolve a sample with 100 mM borate buffer, pH 8.0 containing 2 mM EDTA.
2. Mix 500μl of the sample solution and 500μl of 1 mM ABD-F/100 mM borate buffer in a reaction vial.
3. Heat the vial at 50ºC for 5 minutes and cool it on an ice bath.
4. Add 300μl of 100 mM HCl aqueous solution to the reaction mixture.
5. Use this mixture for HPLC analysis to determine ABD-labeled compounds; excitation: 389 nm, emission: 513 nm.

ABD-F 50mg

Molecular Formula=C₆H₄FN₄O₃S

Molecular Weight: 217.18

CAS: 91366-65-3

Store at -20°C

Synonyms:
7-Fluorobenz-2-oxa-1,3-diazole-4-sulfonamide
4-Fluoro-7-aminosulfonylbenzofurazan
7-Fluoro-4-sulfamoyl-2,1,3-benzoxadiazole
7-Fluorobenzofurazan-4-sulfonamide
4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole
4-(Aminosulfonyl)-7-fluorobenzofurazane
4-(Aminosulphonyl)-7-fluoro-2,1,3-benzoxadiazole
4-Fluoro-7-sulfoamoylbenzofurazan